Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Hyperoxia
Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement.
Oxo-Acid-Lyases
RNA, Ribosomal, 18S
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol. 2005 Oct; 56(1):169-78.
View in:
PubMed
subject areas
Clinical Trials as Topic
Humans
Immunosuppressive Agents
Inflammatory Bowel Diseases
Lymphoma